Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Ward

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Plos One|May 7, 2015
The fishery performance indicators: a management tool for triple bottom line outcomesJames L Anderson, Christopher M Anderson, Jingjie Chu, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
International Journal of Cancer|July 5, 2023
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancerJuan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE studyPhilipp Heumann, Miguel E Aguado-Barrera, Barbara Avuzzi, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE studyLotte van der Weijst, David Azria, Patrick Berkovic, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2024
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre studyMiguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancerPetra Seibold, Adam Webb, Miguel E Aguado-Barrera, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos One|May 7, 2015
The fishery performance indicators: a management tool for triple bottom line outcomesJames L Anderson, Christopher M Anderson, Jingjie Chu, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
International Journal of Cancer|July 5, 2023
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancerJuan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE studyPhilipp Heumann, Miguel E Aguado-Barrera, Barbara Avuzzi, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE studyLotte van der Weijst, David Azria, Patrick Berkovic, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2024
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre studyMiguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancerPetra Seibold, Adam Webb, Miguel E Aguado-Barrera, et al.
Pageof 3